Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Antares Therapeutics logo

Antares Therapeutics

Recent Finacing

Series A

Recent Raise

$177M

Antares is a Scorpion Therapeutics spin-out developing small-molecule precision oncology drugs that leverage proprietary computational and experimental discovery to target previously inaccessible proteins, including transcription factors, with preclinical assets.

Founded 2025
Massachusetts, United States
101-250
Private
antaresrx.com
PitchBook

Highlights

Focus Areas

Biopharma
Biotechnology
Ediscovery
Health Care
Life Science
Manufacturing
Therapeutics

Recent Investors

Abingworth logo
Omega Funds logo
BVF Partners logo
Invus logo
Atlas Venture logo
V
Cormorant Asset Management logo
Vida Ventures logo
Lightspeed Venture Partners logo
Willett Advisors logo
Tenmile logo

Financials

$177M

Total Raised

1

Funding round

11

Investors


Team

Sign in to view the team

Create a free account to see the team members at Antares Therapeutics.